Actionable news
All posts from Actionable news
Actionable news in JUNO: JUNO THERAPEUTICS Inc,

Hedge Funds Abandoning Juno Therapeutics Inc (JUNO) In Droves

Hedge funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At Insider Monkey, we follow over 700 of the best-performing investors and by analyzing their 13F filings, we can determine the stocks that they are collectively bullish on. One such potential stock is Juno Therapeutics Inc (NASDAQ:JUNO), so let’s take a closer look at the sentiment that surrounded it heading into the current quarter.

Biotech Biochemical Stocks Illumina ILMN

Is Juno Therapeutics Inc (NASDAQ:JUNO) the right investment to pursue these days? Money managers are getting less bullish. The number of long hedge fund positions was cut by 13 recently. At the end of this article we will also compare JUNO to other stocks including United Microelectronics Corp (ADR) (NYSE:UMC), Compania Cervecerias Unidas S.A. (ADR) (NYSE:CCU), and Biomed Realty Trust Inc (NYSE:BMR) to get a better sense of its popularity.

According to most market participants, hedge funds are viewed as worthless, outdated investment vehicles of the past. While there are greater than 8,000 funds with their doors open at present, Insider Monkey hones in on only the aristocrats of this club, about 700 funds. These investment experts shepherd the bulk of the smart money’s total asset base, and by monitoring their highest performing investments, Insider Monkey has found a few...